Biomarin Pharmaceutical Inc
XMUN:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
Intrinsic Value
The intrinsic value for
Biomarin Pharmaceutical Inc (BM8) under the Base Case is 69.032 EUR.
Compared with the current market price of 46.355 EUR, the stock appears
Undervalued by 33% .
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Biomarin Pharmaceutical Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Biomarin Pharmaceutical Inc
Earnings Waterfall
Biomarin Pharmaceutical Inc
The intrinsic value for
Biomarin Pharmaceutical Inc (BM8) under the Base Case is 69.032 EUR.
Compared with the current market price of 46.355 EUR, the stock appears Undervalued by 33% .